Daniel Barajas, MD
Obstetrics/Gynecology · West Covina
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 45 years
- Graduated 1981
Offices
2 locations · Emanate Health Medical Care Foundation · 85 clinicians in this group
Looking this up.
Hospitals listed: Emanate Health Inter-Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Barajas’s office at (626) 732-8391 to ask if they take your plan before you enroll.
California Medical Board record
Licence G54362 · Current
Licensed to practise in California · since 1985 · expires 2028-04-30 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Emanate Health Inter-Community HospitalCovina, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Emanate Health Inter-Community Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.4 (0.39 to 2.4) · 990 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.53 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.56 (145.92 to 251.21) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 665 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 389 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 3,599 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,844 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 6,958 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.98 to 5.43) · 1,118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.53 to 3.58) · 1,140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (1.69 to 15.67) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (1.14 to 9) · 397 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.97) · 5,698 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 213 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.853 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.205 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 352 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,007 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (8.8 to 16.5) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 113 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 106 cases | No different | Jan 2024 – Dec 2024 |
What patients said (924 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$3,027
Medicare paid this office $3,027 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 63 · 85 and older 0% · Women 100% · Health risk score 1.28. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
The office billed $13,651, Medicare allowed $3,864 and paid $3,027; for 16 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 16 | 63 | 1.28 | $13,651 | $3,027 |
| 2022 | 16 | 49 | 67 | 2.38 | $10,859 | $3,000 |
| 2021 | 16 | 24 | 66 | 1.47 | $9,258 | $2,324 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$140,580 in 2024
Medicaid paid $140,580 for 2,108 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 724 | $138,394 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 95 | $1,049 |
| Prenatal care, at-risk enhanced service; antepartum management | 328 | $472 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 19 | $335 |
| Short return visit (20+ min) | 31 | $330 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 15 | $0 |
| Service | 563 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 176 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 59 | $0 |
| Prenatal care, at-risk enhanced service; education | 44 | $0 |
| Patient education, not otherwise classified, non-physician provider, individual, per session | 35 | $0 |
| Service | 19 | $0 |
| 2024 | 2,108 | 12 | 47 | $140,580 |
| 2023 | 4,049 | 14 | 44 | $298,775 |
| 2022 | 2,996 | 16 | 57 | $227,248 |
| 2021 | 7,014 | 15 | 117 | $386,810 |
| 2020 | 2,669 | 8 | 35 | $257,103 |
| 2019 | 1,993 | 10 | 33 | $223,726 |
| 2018 | 1,463 | 5 | 33 | $238,735 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,436 | $270,561 |
| OBSTETRICAL CARE | 27 | $11,987 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 226 | $4,666 |
| Service | 127 | $4,331 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 190 | $4,235 |
| Short return visit (20+ min) | 282 | $2,361 |
| Service | 14 | $610 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 13 | $25 |
| Service | 893 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 213 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 147 | $0 |
| Prenatal care, at-risk enhanced service; antepartum management | 312 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 979 | $186,509 |
| Cesarean delivery | 64 | $13,845 |
| OBSTETRICAL CARE | 12 | $5,454 |
| Service | 147 | $5,013 |
| Short return visit (20+ min) | 477 | $4,702 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 243 | $4,637 |
| Return visit (30+ min) | 361 | $3,255 |
| Prenatal care, at-risk enhanced service; antepartum management | 139 | $2,298 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 54 | $1,061 |
| Short return visit | 28 | $473 |
| Service | 265 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 145 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,741 | $324,343 |
| Return visit (30+ min) | 1,439 | $25,339 |
| Service | 457 | $15,584 |
| Cesarean delivery | 26 | $7,691 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 295 | $5,662 |
| New patient visit (60+ min) | 101 | $4,301 |
| Short return visit (20+ min) | 213 | $2,756 |
| Prenatal care, at-risk enhanced service; antepartum management | 196 | $665 |
| Short return visit | 57 | $469 |
| Service | 1,838 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 305 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 38 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,352 | $248,562 |
| New patient visit (45+ min) | 144 | $4,422 |
| Cesarean delivery | 14 | $3,104 |
| New patient visit (30+ min) | 42 | $1,015 |
| Service | 767 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 267 | $0 |
| Service | 63 | $0 |
| Service | 20 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,155 | $210,343 |
| New patient visit (45+ min) | 228 | $5,984 |
| Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 13 | $4,157 |
| New patient visit (30+ min) | 167 | $2,096 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 12 | $748 |
| Short return visit (20+ min) | 39 | $399 |
| Service | 108 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, with microscopy | 171 | $0 |
| Service | 80 | $0 |
| Service | 20 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,310 | $234,833 |
| New patient visit (45+ min) | 57 | $2,010 |
| New patient visit (30+ min) | 71 | $1,035 |
| Ultrasound, pregnant uterus, real time with image documentation, limited (eg, fetal heart beat, placental location, fetal position and/or qualitative amniotic fluid volume), 1 or more fetuses | 12 | $712 |
| Short return visit (20+ min) | 13 | $144 |
Drugs they prescribed that Part D paid
$859
Pharmacies billed $859 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 38) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
30 generic and fewer than 11 brand-name prescriptions · $859 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 11 | $712 | $65 |
Year by year
| 2024 | 38 | 19 | 0% (0) | None | $859 |
| 2023 | 41 | 24 | None | None | $1,743 |
| 2022 | 36 | 14 | None | None | $1,366 |
| 2021 | 70 | 25 | None | None | $1,588 |
| 2020 | 108 | 33 | None | 17% | $2,274 |
| 2019 | 112 | 33 | None | None | $4,996 |
| 2018 | 80 | 26 | None | 20% | $12,167 |
| 2017 | 49 | 23 | None | 24% | $1,138 |
| 2016 | 47 | 28 | None | 40% | $2,458 |
| 2015 | 59 | 32 | 0% (0) | 42% | $3,570 |
| 2014 | 42 | 19 | None | 64% | $2,375 |
| 2013 | 72 | 24 | None | 46% | $4,096 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 4 drugs
| Atorvastatin | 12 | $146 | $12 |
| Cephalexin | 12 | $81 | $7 |
| Ramipril | 12 | $68 | $6 |
| Metformin | 12 | $35 | $3 |
2019: 3 drugs
| Atorvastatin | 12 | $197 | $16 |
| Ramipril | 12 | $87 | $7 |
| Metformin | 11 | $34 | $3 |
2015: 1 drug
| Clindamycin Phosphate | 12 | $775 | $65 |
2014: 1 drug
| Clindamycin Phosphate | 24 | $1,622 | $68 |
2013: 1 drug
| Clindamycin Phosphate | 12 | $770 | $64 |
Money from drug and device companies
$23 in 2024
| 2024 | 1 | 1 | None | $23 |
| 2022 | 1 | 1 | None | $24 |
| 2021 | 1 | 2 | None | $38 |
| 2020 | 1 | 4 | None | $80 |
| 2019 | 5 | 9 | None | $238 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Hologic Sales and Service | Aptima | $23 | 1 payment
|
See the published payment
| Hologic Sales and Service | Meals · 2024-06-06 | Aptima | $23 |
See earlier years (2022, 2021, 2020, 2019)
2022: $24
| Channel Medsystems | None | $24 | 1 payment
|
2021: $38
| AbbVie | Orilissa | $38 | 2 payments
|
2020: $80
| AbbVie | Orilissa | $80 | 4 payments
|
2019: $238
| AbbVie | Orilissa | $72 | 3 payments
|
| Avanos Medical | On-Q* Pump and Accessories | $69 | 1 payment
|
| Roche Diagnostics | Rs Harmony Test Related Products | $64 | 3 payments
|
| AMAG Pharmaceuticals | Intrarosa | $18 | 1 payment
|
| Allergan | Lo Loestrin Fe | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 79.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1316029317
- Licence
- CA G54362California G54362: Current · expires 2028-04-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 222 N Sunset Ave, Suite E, West Covina, CA, 91790
- NPI first listed
- 2006-10-19
- NPI last updated
- 2011-08-09
This is when the NPI record was last certified, not a medical board exam.